Skip to main content

Published locations for Ixekizumab surpasses adalimumab in PsA head-to-head study

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ixekizumab surpasses adalimumab in PsA head-to-head study

User login

  • Reset your password
  • /content/ixekizumab-surpasses-adalimumab-psa-head-head-study
  • /edermatologynews/article/202988/psoriatic-arthritis/ixekizumab-surpasses-adalimumab-psa-head-head
  • /internalmedicinenews/article/202988/psoriatic-arthritis/ixekizumab-surpasses-adalimumab-psa-head
  • /rheumatologynews/article/202988/psoriatic-arthritis/ixekizumab-surpasses-adalimumab-psa-head-head
  • /rheumatology/article/202988/psoriatic-arthritis/ixekizumab-surpasses-adalimumab-psa-head-head-study
  • /internalmedicine/article/202988/psoriatic-arthritis/ixekizumab-surpasses-adalimumab-psa-head-head
  • /dermatology/article/202988/psoriatic-arthritis/ixekizumab-surpasses-adalimumab-psa-head-head-study
  • /rheumatology/psoriatic-arthritis-resource-center/article/202988/psoriatic-arthritis/ixekizumab
  • /psoriatic-arthritis-icymi/article/202988/psoriatic-arthritis/ixekizumab-surpasses-adalimumab-psa